| Name | Title | Contact Details |
|---|
St Vincent Infirmary Medical Center is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Fox Chase Cancer Center, defeating cancer is our calling. Fox Chase is one of the nation`s first dedicated cancer hospitals, and our researchers and physicians have made major contributions to scientific advancement since our establishment more than a century ago in 1904. Fox Chase scientists have made breakthroughs in cancer prevention, diagnosis, treatment, and survivorship, and have earned the highest awards in their fields, including two Nobel Prizes. We translate these pioneering discoveries into world-class clinical care every day - with a single purpose: to defeat cancer and help the people it impacts. This calling is rooted in our cancer-specific, multidisciplinary teams of doctors, researchers, practitioners, and five-time Magnet designated nurses, who are all more than specialists in cancer; they are international experts in distinct types of cancer, whose deep and focused expertise provides the best chance for the best outcome anywhere along the cancer continuum. And they`re helping to advance the way cancer treatment is delivered around the world. The way we work together, with this single, shared passion for our patients` well-being, is what makes us truly unique.
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Applied Medical Services is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fruit Street delivers the CDC`s Diabetes Prevention Program using telehealth, wearable devices, and mobile applications. The diabetes prevention program is a 1-year long diet and lifestyle intervention designed to help pre-diabetic patients lose 5-7% of their weight through diet and lifestyle changes. The program is based on clinical research that was published in the New England Journal of Medicine in 2002 which showed that patients who complete the program have a 58% risk reduction for developing diabetes.